Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Lawrence Ricketts, Executive Vice President and COO of One Liberty Properties INC (NASDAQ: OLP), sold 3,992 shares of company stock on March 16 and 17, 2026, generating proceeds of $93,031. The trades occurred as the company continued to announce industrial property acquisitions, declared its 133rd consecutive quarterly dividend, and carried a divi…
Axogen Chief Innovation Officer Erick Wayne DeVinney sold a block of shares on March 16, 2026, after exercising options and seeing restricted stock units vest. The moves included a sale to cover tax obligations tied to vesting, and occurred amid recent strong share gains and a mixed market response to the company’s fourth-quarter 2025 results.
Tarsus Pharmaceuticals director William J. Link sold 12,490 shares on March 16, 2026, generating about $859,818 across three transactions executed under a Rule 10b5-1 trading plan. The company also reported strong fourth-quarter and full-year 2025 product sales, led by XDEMVY, though its shares dipped slightly in aftermarket trading.
Alane P. Barnes, Chief Legal Officer of BioCryst Pharmaceuticals Inc., executed an automatic insider transaction plan on March 16, 2026, exercising options to acquire 150,000 shares and selling 150,000 shares of common stock. The sale totaled $1,372,500 at a weighted average price of $9.15, while the option exercise cost $826,500. Following the act…
Agilysys INC director Melvin L. Keating bought 390 shares of common stock between March 16 and March 17, 2026, spending $27,289. The purchases were filed on a Form 4 and executed at prices between $67.98 and $68.49. The stock has traded near its 52-week low amid a 43% year-to-date decline and the company recently reported record revenue but an earn…
Root Inc.'s Chief Administrative Officer, Jonathan Allison, sold 3,990 shares of Class A common stock on March 17, 2026, for $45.00 per share under a 10b5-1 trading arrangement, realizing $179,550. The transaction leaves Allison with 85,989 directly held shares. The sale coincides with ROOT trading close to a 52-week low and follows the company's f…
Hims & Hers Health COO Michael Chi executed a sale of 97,289 Class A shares on March 17, 2026, for $24.69 per share under an existing Rule 10b5-1 plan, netting about $2.4 million. The transaction leaves Chi with 407,282 shares. The sale coincides with significant corporate developments including a collaboration with Novo Nordisk, an analyst upgrade…
A hacker using the name "Internet Yiff Machine" says they penetrated P3 Global Intel, a tip intelligence unit of Navigate360, and exfiltrated roughly 93 gigabytes containing more than 8 million confidential tips. The intruder claims to have used social engineering to seize a customer account before exploiting a vulnerability to download the data. S…
Opus Genetics Chief Operating Officer Joseph K. Schachle completed an automatic sale of 3,719 shares on March 16, 2026, yielding $19,525 to satisfy tax withholding tied to restricted stock unit vesting. The disposition occurs while Opus Genetics shares trade near a 52-week high amid recent clinical progress and a $25 million capital raise.
Esperion Therapeutics President and CEO Sheldon L. Koenig sold 25,578 shares on March 17, 2026, generating $69,546 at $2.719 per share. The sale, disclosed in an SEC filing, was made to satisfy tax obligations on vested restricted stock units. Esperion reported mixed fourth-quarter 2025 results and noted regulatory guideline recognition for its cho…
Esperion Therapeutics Chief Financial Officer Benjamin Halladay sold 6,424 shares on March 17, 2026, for $2.705 per share, a transaction totaling $17,376 intended to cover tax liabilities tied to vested restricted stock units. The sale was disclosed in an SEC Form 4 filed March 18, 2026; after the trade Halladay retained direct ownership of 713,602…
Control Empresarial de Capitales S.A. de C.V., which holds roughly ten percent of PBF Energy Inc. (NYSE: PBF), sold 650,700 Class A common shares on March 16 and 17, 2026, generating about $28.8 million. The transactions occurred while the stock was trading close to its 52-week high and following PBF's fourth-quarter 2025 earnings beat, which showe…
Qnity Electronics saw its stock tick up 2% in after‑hours trading Wednesday after announcing a collaboration with NVIDIA. The agreement will apply NVIDIA’s accelerated computing technologies to materials modeling and simulation across the semiconductor value chain, with an explicit focus on materials R&D for AI, high‑performance computing and advan…
Howmet’s mix of aftermarket pricing power, constrained titanium/forging capacity and a cleaner balance sheet creates a favorable risk-reward for a mid-term long. Entry at $243 with a $280 target and $225 stop reflects a trade that leans on catalysts (defense spend, acquisitive bolt-ons, and resin-tight supply) and a path to re-rating if margins exp…
Sweden says a Swedish national detained in Iran since June of last year was executed on Wednesday. The Swedish foreign minister summoned Iran’s ambassador in Stockholm and criticized the legal proceedings as falling short of due process, while the EU’s foreign policy chief condemned the execution and expressed condolences to the family.
Privia Health Group, Inc. Executive Vice President and Chief Financial Officer David Mountcastle sold 6,391 shares on March 16, 2026, to meet tax withholding obligations related to vested performance stock units. The sale, recorded on an SEC Form 4, amounted to $141,305 at a per-share price of $22.11. The transaction took place while the stock trad…
Avalo Therapeutics Inc. (NASDAQ: AVTX) Chief Medical Officer Mittie Doyle sold 25,492 common shares on March 16, 2026, for $411,606 following the exercise of options to acquire an identical number of shares. The transactions coincide with recent analyst interest and a marked year-over-year share gain, while InvestingPro data flags the stock as trad…
Opus Genetics Chief Scientific & Development Officer Jayagopal Ashwath sold 3,719 shares on March 16, 2026, to satisfy tax withholding tied to vesting restricted stock units. The transaction, executed at a weighted average price of $5.1213 per share, left Ashwath with 516,775 directly held shares. The company also reported early, favorable safety d…
Guidewire Software Inc's Chief Executive Officer, Michael George Rosenbaum, sold 4,737 shares on March 17, 2026, generating $776,194 at $163.8579 per share. The sale, disclosed as a tax-covering move tied to the settlement of Restricted Stock Units, leaves Rosenbaum with 221,206 directly held shares. The transaction comes while the stock has fallen…
Micron Technology forecast third-quarter revenue well above analyst expectations, citing surging demand for memory chips used in artificial intelligence hardware and long-term customer commitments to data center expansion. The company also lifted its fiscal 2026 capital expenditure outlook and said construction-related spending will rise materially…
K. Christopher Farkas, Executive Vice President and Chief Financial Officer of Curtiss-Wright Corporation (NYSE: CW), sold 918 shares of common stock on March 17, 2026, to satisfy tax obligations related to the vesting of restricted stock units. The transactions followed the exercise of 2,183 RSU-derived shares on March 16, 2026. Curtiss-Wright als…
Swarmer Inc completed an initial public offering priced at $5.00 per share and began trading on the Nasdaq Capital Market under the ticker SWMR. The company closed an offering of 3,450,000 shares, with underwriters exercising their full option to buy an additional 450,000 shares, and expects net proceeds of roughly $14.7 million to support operatio…
Murray Stahl, President and Co-Portfolio Manager of RENN Fund, Inc. (EXCHANGE:RCG), purchased 1,134 common shares on March 17, 2026, at $3.27 per share, a price that matches the stock's 52-week high. The total value of the transactions was $3,708. Stahl's direct stake increased to 155,654 shares, and additional shares were allocated to accounts and…
IAU (iShares Gold Trust) offers low-cost, liquid exposure to physical gold. After a steep rebound from last year's lows and a recent pullback from $104.40, the ETF is trading at $91.14 and looks set up for a mid-term trade into a renewed risk-off or weaker dollar. This trade pairs a pragmatic entry, a conservative stop and a realistic target tied t…
Wesbanco director Kerry M Stemler disclosed purchases of WSBC common stock on March 18, 2026, totaling $30,800 across multiple transactions. The buys leave Stemler with a substantial direct and indirect holding. The disclosure comes as the bank reports mixed Q4 2025 results, announces a commercial expansion into South Florida with new hires, and it…
